Combioxin SA
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae (NCT02583373) | Combioxin SA | 2016-03-21 |
Track Combioxin SA automatically
Every clearance here is in the API, with alerts when new ones post.